Novo invests $100M in Denmark plant; Alliance wants $200M more for FDA budget; Sagent has $500M for new products;

@FiercePharma: Top-read FP news yesterday: CA panel shivs Gilead's Sovaldi on price, suggests focusing it on sickest hep C patients. Story | Follow @FiercePharma

@TracyStaton: In other India news, Dr. Reddy's pulls 58K bottles of generic Prevacid on microbial contamination. More from Reuters | Follow @TracyStaton

@EricPFierce: Pharma cargo theft are on the rise again with a 50% bump in truckload rip-offs. News | Follow @EricPFierce

@CarlyHFierce: On that note, here's a story I wrote yesterday about dying cattle (and Merck). Article | Follow @CarlyHFierce

> Novo Nordisk ($NVO) will invest about $100 million in a purification plant in Denmark to make more ingredients for its diabetes drugs. News

>  The Alliance for a Stronger FDA is asking Congress to raise the FDA budget next year by $200 million to $2.784 billion. Release

> India's Supreme Court ruled in favor of a public interest investigation into whether Ranbaxy Laboratories supplied adulterated drugs in the country. More

> Generic injectable drugmaker Sagent Pharmaceuticals is looking to spend up to $500 million on products to shore up its portfolio. Story

> FDA Commissioner Margaret Hamburg told Congress that the FDA is working with the FTC and the National Coordinator for Health Information Technology to create a mandated framework for regulating healthcare IT. Story

Medical Device News

@FierceMedDev: Another med tech IPO reveal, though K2M hinted in Jan. that this was coming. S-1 | Follow @FierceMedDev

@MarkHFierce: Boston Scientific  isn't giving up on bare metal stents, not by a long shot. Smart move. Story | Follow @MarkHFierce

@MichaelGFierce: Mallinckrodt's U.S. pain drug approval brings Depomed a $10M delivery tech milestone. More from FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: Breathing machines made from aquarium pumps could boost preemie survival rates, say researchers at Rice University. Article | Follow @EmilyWFierce

> Stentys touts a revenue bump and cash to burn for its U.S. push. More

> Hologic adds a COO, loses a CFO in a C-level shakeup. Story

> Sorin snatches up a Florida manufacturer's cardiac-lead business for $20M. News

> French surgeons perform closed-heart surgery using a nitinol stent. Item

Biotech News

@FierceBiotech: A who's-that of biotechs snag $119M as the IPO market thunders on. More | Follow @FierceBiotech

@JohnCFierce: Leerink's Liang is reducing price target on Aveo. The CMO has left. Execs giving up on a program, credibility is shot. | Follow @JohnCFierce

@DamianFierce: U.K. joins the 'breakthrough' bandwagon with new fast-track program. Story | Follow @DamianFierce

@EmilyMFierce: STAP stem cell scientists criticized by RIKEN for "inappropriate" behavior. No intentional misconduct ID'd so far. Story via LA Times | Follow @EmilyMFierce

> Chelsea Therapeutics and the return of pharma's phantom checkbook. Article

> Time, distance and the new world of online business news. Opinion

And Finally... Author Barry Werth who wrote The Billion Dollar Molecule: The Quest for the Perfect Drug, about the quest by Vertex Pharmaceuticals ($VRTX) to bring a drug to market, is back 20 years later with a book on the relationship between drugs and money. Review